-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GRS in Stable Angina
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRS in Stable Angina Drug Details: Small molecule is under development for the treatment of...
-
New
![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Dependence
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Dependence Drug Details: PT-150 is under development for the treatment of opioid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Dependence
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Dependence Drug Details: PT-150 is under development for the treatment of opioid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Smoking Cessation Drug Details: PT-150 is under development for the treatment of opioid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Opium (Opioid) Addiction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Opium (Opioid) Addiction Drug Details: PT-150 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CORT-108297 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CORT-108297 in Alzheimer's DiseaseDrug Details:CORT-108297 is under development for the treatment of Alzheimer's disease andPost-traumatic stress...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CORT-108297 in Post-Traumatic Stress Disorder (PTSD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CORT-108297 in Post-Traumatic Stress Disorder (PTSD)Drug Details:CORT-108297 is under development for the treatment of Alzheimer's disease...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Addiction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Addiction Drug Details: PT-150 is under development for the treatment of opioid...
-
Product Insights
New![]()
Portable Oxygen Concentrators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Portable Oxygen Concentrators Pipeline Market Report Overview A Portable Oxygen Concentrator provides a continuous flow of oxygen by separating oxygen from room air and further compressing it followed by its filtration with the help of a molecular sieve. The Portable Oxygen Concentrators pipeline market research report provides comprehensive information about the Portable Oxygen Concentrators pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories...
-
Product Insights
New![]()
Net Present Value Model: Corcept Therapeutics Inc’s Relacorilant
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Corcept Therapeutics Inc's Relacorilant Drug Details: Relacorilant (CORT-125134) is under development for the treatment of endogenous Cushing's syndrome, advanced/metastatic solid tumors such as platinum-resistant...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.